fbpx
QQQ
-0.55
290.93
-0.19%
DIA
+ 1.73
290.79
+ 0.59%
SPY
+ 1.01
354.35
+ 0.28%
TLT
-0.81
162.32
-0.5%
GLD
-3.40
179.15
-1.93%

Auxly Posts Q2 Results, Sees YoY Revenue Spike Of 200%

August 28, 2020 2:25 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Auxly Cannabis Group Inc. (OTCQX:CBWTFreported Friday earnings report for the second quarter and the first half of 2020. 

The Toronto-based company reported total revenues of $8.6 million, up by 200% year-over-year. The amount includes $6.8 million of cannabis net revenues and $1.8 million of research revenues from KGK.

"We are excited to have another successful quarter of cannabis sales behind us," said Auxly CEO Hugo Alves, adding they are executing their business strategy while being "committed to doing so with the highest degree of fiscal discipline."

Earnings Breakdown

  • Net loss doubled over the year to $29.2 million in the second quarter
  • For the six months ended June 30, net loss amounted to $42.3 million compared to $28 million in the same period of last year
  • Negative adjusted EBITDA (non-IFRS measure) of $7.8 million in the second quarter of 2020 compared to a loss of $8 million in the corresponding quarter of 2019
  • For the first half of 2020 adjusted EBITDA (non-IFRS measure) was a loss of about $16 million versus a loss of $15.4 in the same period of 2019
  • Cash and equivalents decreased by 53% over the first six months of this year to $20.7 million
  • Debt rose by 9% to $104 million over the same period
  • Gross profit was $2.7 million, while total expenses amounted to $19.5 million

Quarterly Milestones

During the quarter, Auxly's Joint Venture Partner Sunens obtained a cultivation license for the first phase of its 360,000 square-foot greenhouse facility.

Moreover, in April, its subsidiary Dosecann LD Inc. inked a supply deal with Medical Cannabis by Shoppers Drug Mart's online medical cannabis platform, to provide Canadian consumers with cannabis products. Dosecann also received Health Canada's Cannabis Research Licence.

In addition, Auxly secured $25 million in financing through a deal with an undisclosed institutional investor to fund the launch of so-called cannabis 2.0 products.


Related Articles

Mexico's Cannabis Legalization Bill Will Boost Business, But There Are Concerns

Mexican Senators approved a historic adult use cannabis legalization bill on Nov. 19, with an 82 to 18 vote. read more

Panaxia And Neuraxpharm Advance Partnership To Bring Medical Cannabis To France

Israel medical cannabis producer Panaxia Labs Israel (TASE: PNAX) and European pharmaceutical company Neuraxpharm are planning to reach the French market. read more

Viola Flowers Reach MedMen's Shelves In California

MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) is teaming up with Al Harrington’s Viola. read more

New Cannabis Products: Live Resin Edibles, Infused Olive Oil, High Dose CBD Beverages

As the cannabis market expands, it's difficult to keep track of the many products that launch every week. Benzinga put together a short list of some of the most interesting new cannabis products. read more

What To Do With Your Cannabis Stalks, Stems And Leaves

This article was originally published on Cannabis & Tech Today, and appears here with permission. You lovingly raised your cannabis crop from seed to flower; you harvested those beautifully frosted buds, trimmed, washed, and dried them; and now, you can enjoy the fruits of your labor with a truly excellent toke. read more